---
category: news
title: "Study says Abbott’s HeartMate3 heart pump extends survival by 5 years"
excerpt: "Abbott (NYSE:ABT) announced today that data demonstrates extended survival for advanced heart failure patients using HeartMate 3. Data from the Momentum 3 trial — the world’s largest randomized clinical trial to assess long-term outcomes in people receiving a left ventricular assist device (also known as an LVAD or heart pump) to treat advanced heart failure"
publishedDateTime: 2022-08-29T14:22:00Z
originalUrl: "https://www.massdevice.com/data-abbott-heartmate3-heart-pump-survival/"
webUrl: "https://www.massdevice.com/data-abbott-heartmate3-heart-pump-survival/"
type: article

provider:
  name: MassDevice
  domain: massdevice.com

topics:
  - AI in Healthcare
  - AI

secured: "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;O8vTwwC56pGSE0Aiyxa6Xg=="
---

